Inotropic and diuretic effects of exendin and GLP-1

Details for Australian Patent Application No. 2006252240 (hide)

Owner Amylin Pharmaceuticals, Inc.

Inventors Vine, Will; Beeley, Nigel R. A; Young, Andrew A; Prickett, Kathryn

Agent Spruson & Ferguson

Pub. Number AU-B-2006252240

Parent 2003200908

Filing date 22 December 2006

Wipo publication date 25 January 2007

Acceptance publication date 19 February 2009

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A01N 37/18 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids - containing the group CON, e.g. carboxylic acid amides or imides

A61P 7/10 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

18 January 2007 Complete Application Filed

25 January 2007 Application Open to Public Inspection

  Published as AU-B-2006252240

19 February 2009 Application Accepted

  Published as AU-B-2006252240

18 June 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006252241-EG-VEGF nucleic acids and polypeptides and methods of use

2006252239-Barcode pattern